Nov 3, 2021 | biomarkers, health policy, innovation, oncology, precision medicine |
because we know that cancer can be highly variable from one person to the other, based on the changes at the molecular level, each patient, even those with the same diagnosis, have a unique set of changes that influence how a person will respond to therapy, or how...
Jun 28, 2021 | innovation, precision medicine |
this is a guest article and does not necessarily reflect the views and values of the cancer collaborative. the original article was created by Impetus Digital and can be found here. Wearable technologies are gaining a lot of interest as a means of data collection in...
Nov 17, 2020 | biosimilars, innovation, oncology |
here’s how biologics have become an important part in the cancer landscape, providing better outcomes for some patients . because they are made from living organisms biologics can not be exactly copied [generics]. the complex manufacturing process of biologics...
Jun 23, 2020 | #travelwithcolab, asco, innovation, oncology |
for the first time since its inception in 1965, the ASCO scientific conference was held virtually amid the COVID 19 pandemic. this did not stop the global oncology community from convening during three days [from may 29-31] to accelerate progress together. on june 4th...
Feb 12, 2020 | asco, innovation, oncology, precision medicine |
ASCO has published their annual report on progress against cancer – the report highlights the most important clinical research advances of the past year and identifies priority areas where ASCO believes research efforts should focus moving forward. this year the...
